ARS Pharmaceuticals Inc SPRY:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:37 PM EDT
8.81quote price arrow down-0.17 (-1.89%)
Volume
332,032
52 week range
2.55 - 11.27
Loading...
  • Open9.10
  • Day High9.23
  • Day Low8.77
  • Prev Close8.98
  • 52 Week High11.27
  • 52 Week High Date03/28/24
  • 52 Week Low2.55
  • 52 Week Low Date09/20/23

Key Stats

  • Market Cap853.647M
  • Shares Out96.90M
  • 10 Day Average Volume0.30M
  • Dividend-
  • Dividend Yield-
  • Beta0.88
  • YTD % Change61.68

KEY STATS

  • Open9.10
  • Day High9.23
  • Day Low8.77
  • Prev Close8.98
  • 52 Week High11.27
  • 52 Week High Date03/28/24
  • 52 Week Low2.55
  • 52 Week Low Date09/20/23
  • Market Cap853.647M
  • Shares Out96.90M
  • 10 Day Average Volume0.30M
  • Dividend-
  • Dividend Yield-
  • Beta0.88
  • YTD % Change61.68

RATIOS/PROFITABILITY

  • EPS (TTM)-0.52
  • P/E (TTM)-16.95
  • Fwd P/E (NTM)-13.55
  • EBITDA (TTM)-61.935M
  • ROE (TTM)-20.49%
  • Revenue (TTM)10,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-496,960.00%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ARS Pharmaceuticals Inc

 

Profile

MORE
ARS Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing neffy, for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, administered and nasal spray. Type I allergic reactions are potentially life-threatening...
Pratik Shah Ph.D.
Independent Chairman of the Board
Richard Lowenthal
President, Chief Executive Officer, Director
Brian Dorsey
Chief Operating Officer
Kathleen Scott
Chief Financial Officer
Address
11682 El Camino Real, Suite 120
San Diego, CA
92130
United States

Top Peers

SYMBOLLASTCHG%CHG
HUMA
Humacyte Inc
7.30+0.15+2.17%
SRRK
Scholar Rock Holding Corp
10.21-0.46-4.31%
IRON
Disc Medicine Inc
33.69-0.59-1.72%
TYRA
Tyra Biosciences Inc
16.23-1.09-6.27%
PRME
Prime Medicine Inc
6.47-0.46-6.57%